BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28426265)

  • 1. Transdermal iontophoresis patch with reverse electrodialysis.
    Lee J; Kwon K; Kim M; Min J; Hwang NS; Kim WS
    Drug Deliv; 2017 Nov; 24(1):701-706. PubMed ID: 28426265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel reverse electrodialysis-driven iontophoretic system for topical and transdermal delivery of poorly permeable therapeutic agents.
    Kim KT; Lee J; Kim MH; Park JH; Lee JY; Song JH; Jung M; Jang MH; Cho HJ; Yoon IS; Kim DD
    Drug Deliv; 2017 Nov; 24(1):1204-1215. PubMed ID: 28844174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic delivery of transdermal patches containi.
    Yu T; Zhang S; Cao X; Liu C
    Acta Biochim Pol; 2019 Apr; 66(2):167-172. PubMed ID: 30986279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated Transdermal Drug Delivery Using Nanocarriers-Embedded Electroconductive Hydrogel Coupled with Reverse Electrodialysis-Driven Iontophoresis.
    An YH; Lee J; Son DU; Kang DH; Park MJ; Cho KW; Kim S; Kim SH; Ko J; Jang MH; Lee JY; Kim DH; Hwang NS
    ACS Nano; 2020 Apr; 14(4):4523-4535. PubMed ID: 32191436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic transdermal iontophoresis patch with built-in biofuel cell.
    Ogawa Y; Kato K; Miyake T; Nagamine K; Ofuji T; Yoshino S; Nishizawa M
    Adv Healthc Mater; 2015 Mar; 4(4):506-10. PubMed ID: 25402232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
    Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
    Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
    Wang Y; Zeng L; Song W; Liu J
    Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery.
    Li Y; Yang J; Zheng Y; Ye R; Liu B; Huang Y; Zhou W; Jiang L
    Acta Biomater; 2021 Feb; 121():349-358. PubMed ID: 33340733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous concentrations following topical iontophoretic delivery of diclofenac.
    Kasha PC; Anderson CR; Morris RL; Sembrowich WL; Chaturvedula A; Banga AK
    Drug Discov Ther; 2012 Oct; 6(5):256-62. PubMed ID: 23229146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
    Calatayud-Pascual MA; Balaguer-Fernández C; Serna-Jiménez CE; Del Rio-Sancho S; Femenía-Font A; Merino V; López-Castellano A
    Int J Pharm; 2011 Sep; 416(1):189-94. PubMed ID: 21736929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine.
    Dasgupta R; Banthia AK; Tibarewala DN
    Curr Drug Deliv; 2009 Apr; 6(2):145-50. PubMed ID: 19450220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.
    Singhal M; Serna C; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2021 Sep; 166():175-181. PubMed ID: 34175373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microporation on passive and iontophoretic delivery of diclofenac sodium.
    Patel H; Joshi A; Joshi A; Stagni G
    Drug Dev Ind Pharm; 2015; 41(12):1962-7. PubMed ID: 25758411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
    Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
    AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.